A-242: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== A-242 == | |||
[[File:Novichok_A242_(Mirzayanov_2009).svg|thumb|right|Chemical structure of A-242]] | |||
'''A-242''' is a chemical compound that belongs to the class of [[nerve agents]] known as [[Novichok agents]]. These agents were developed by the [[Soviet Union]] during the late stages of the [[Cold War]] as part of a program to create more potent chemical weapons that could evade international detection and bans. | |||
A-242 is | |||
== | === Chemical Properties === | ||
A-242 is an organophosphate compound, which means it contains phosphorus bonded to carbon and oxygen atoms. Like other nerve agents, it functions by inhibiting the enzyme [[acetylcholinesterase]], leading to an accumulation of [[acetylcholine]] in the [[synaptic cleft]] and causing continuous stimulation of [[muscles]], [[glands]], and [[central nervous system]] functions. | |||
==Symptoms of | === Mechanism of Action === | ||
Exposure to A-242 can | The primary mechanism of action for A-242, as with other nerve agents, is the irreversible inhibition of acetylcholinesterase. This enzyme is crucial for breaking down acetylcholine, a neurotransmitter, in the synaptic cleft. When acetylcholinesterase is inhibited, acetylcholine accumulates, resulting in overstimulation of [[muscarinic]] and [[nicotinic]] receptors. This leads to symptoms such as [[muscle twitching]], [[respiratory failure]], and [[seizures]]. | ||
=== Symptoms of Exposure === | |||
Exposure to A-242 can result in a range of symptoms, depending on the dose and route of exposure. Common symptoms include: | |||
* [[Miosis]] (constricted pupils) | * [[Miosis]] (constricted pupils) | ||
* [[ | * [[Bronchoconstriction]] | ||
* [[Bradycardia]] (slow heart rate) | |||
* [[ | * [[Muscle weakness]] | ||
* [[Muscle | * [[Convulsions]] | ||
* [[ | |||
* [[Coma]] | * [[Coma]] | ||
==Treatment== | === Treatment === | ||
The treatment for A-242 | The treatment for exposure to A-242 involves the administration of [[atropine]], which blocks the effects of acetylcholine at muscarinic receptors, and [[pralidoxime]], which can reactivate acetylcholinesterase if administered soon after exposure. Supportive care, including [[ventilation]] and [[seizure control]], is also critical. | ||
==History | === Development and History === | ||
A-242 was | The development of A-242 and other Novichok agents was part of a secretive Soviet program aimed at creating chemical weapons that could bypass existing arms control measures. The existence of these agents was revealed by [[Vil Mirzayanov]], a former Soviet scientist, who disclosed details about the program in the 1990s. | ||
== Related Pages == | |||
==Related | |||
* [[Nerve agent]] | * [[Nerve agent]] | ||
* [[ | * [[Acetylcholinesterase]] | ||
* [[Organophosphate poisoning]] | |||
* [[Chemical warfare]] | * [[Chemical warfare]] | ||
[[Category:Nerve agents]] | [[Category:Nerve agents]] | ||
[[Category:Organophosphates]] | [[Category:Organophosphates]] | ||
[[Category:Chemical | [[Category:Chemical warfare agents]] | ||
Latest revision as of 11:52, 15 February 2025
A-242[edit]
A-242 is a chemical compound that belongs to the class of nerve agents known as Novichok agents. These agents were developed by the Soviet Union during the late stages of the Cold War as part of a program to create more potent chemical weapons that could evade international detection and bans.
Chemical Properties[edit]
A-242 is an organophosphate compound, which means it contains phosphorus bonded to carbon and oxygen atoms. Like other nerve agents, it functions by inhibiting the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft and causing continuous stimulation of muscles, glands, and central nervous system functions.
Mechanism of Action[edit]
The primary mechanism of action for A-242, as with other nerve agents, is the irreversible inhibition of acetylcholinesterase. This enzyme is crucial for breaking down acetylcholine, a neurotransmitter, in the synaptic cleft. When acetylcholinesterase is inhibited, acetylcholine accumulates, resulting in overstimulation of muscarinic and nicotinic receptors. This leads to symptoms such as muscle twitching, respiratory failure, and seizures.
Symptoms of Exposure[edit]
Exposure to A-242 can result in a range of symptoms, depending on the dose and route of exposure. Common symptoms include:
- Miosis (constricted pupils)
- Bronchoconstriction
- Bradycardia (slow heart rate)
- Muscle weakness
- Convulsions
- Coma
Treatment[edit]
The treatment for exposure to A-242 involves the administration of atropine, which blocks the effects of acetylcholine at muscarinic receptors, and pralidoxime, which can reactivate acetylcholinesterase if administered soon after exposure. Supportive care, including ventilation and seizure control, is also critical.
Development and History[edit]
The development of A-242 and other Novichok agents was part of a secretive Soviet program aimed at creating chemical weapons that could bypass existing arms control measures. The existence of these agents was revealed by Vil Mirzayanov, a former Soviet scientist, who disclosed details about the program in the 1990s.
.svg){kind=link}